Vaishali Thakkar
Overview
Explore the profile of Vaishali Thakkar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khatri B, Thakkar V, Dalwadi S, Shah A, Rana H, Shah P, et al.
Pharm Nanotechnol
. 2024 Jul;
13(1):199-211.
PMID: 39039683
Background: Malaria remains a formidable public health obstacle across Africa, Southeast Asia, and portions of South America, exacerbated by resistance to antimalarial medications, such as artemisinin-based combinations. The combination of...
2.
Rana H, Panchal M, Thakkar V, Gandhi T, Dholakia M
Heliyon
. 2024 Apr;
10(8):e29543.
PMID: 38660288
Tadalafil (TDL) has poor bioavailability due to the less aqueous solubility and bitter taste. Oral solid dosage forms, especially tablets, have a broad market worldwide. Constraints of tablets are a...
3.
Dalwadi S, Thakkar V, Prajapati B
Pharm Nanotechnol
. 2024 Apr;
13(1):184-198.
PMID: 38616760
Background: Dementia associated with Alzheimer's disease (AD) is a neurological disorder. AD is a progressive neurodegenerative condition that predominantly impacts the elderly population, although it can also manifest in younger...
4.
Modi C, Sinha M, Thakkar V, Rana H, Chavda D
Recent Adv Drug Deliv Formul
. 2024 Mar;
18(2):110-119.
PMID: 38500286
Objective: The primary limitations of tadalafil in treating erectile dysfunction are its low solubility and unpleasant bitter taste, which ultimately result in inadequate patient adherence. The present study aimed to...
5.
Fabrication and In Vitro Evaluation of Febuxostat Tablet for Obtaining Biphasic Drug Release Profile
Chavda D, Joshi D, Thakkar V, Gandhi T
Recent Adv Drug Deliv Formul
. 2022 Nov;
16(4):317-327.
PMID: 36397626
Aim And Objective: The primary aim of the present investigation was to adopt the concept of quality by design (QbD) for developing Febuxostat matrix tablets containing a novel combination of...
6.
Arora U, Thakkar V, Baldaniya L, Gohel M
Drug Dev Ind Pharm
. 2020 Oct;
46(12):1927-1946.
PMID: 33026265
The present study was designed to formulate and develop fast disintegrating pellets of poorly soluble model drug (cilostazol) by reducing the proportion of micro-crystalline cellulose with pre-gelatinized starch (PGS), lactose...
7.
Development of Biodegradable Injectable In situ Forming Implants for Sustained Release of Lornoxicam
Christian R, Thakkar V, Patel T, Gohel M, Baldaniya L, Shah P, et al.
Curr Drug Deliv
. 2018 Sep;
16(1):66-78.
PMID: 30264681
Objective: The focus of this study was to develop in situ injectable implants of Lornoxicam which could provide sustained drug release. Methods: Biodegradable in situ injectable implants were prepared by...
8.
Thakkar V, Korat V, Baldaniya L, Gohel M, Gandhi T, Patel N
Int J Pharm Investig
. 2016 Sep;
6(3):158-68.
PMID: 27606259
Introduction: The aim of burn management and therapy is fast healing and epithelisation to prevent infection. The present study is concerned with the development and characterization of a novel nanaoparticulate...
9.
Tandel D, Shah P, Patel K, Thakkar V, Patel K, Gandhi T
J Chromatogr Sci
. 2016 Sep;
54(10):1827-1833.
PMID: 27601045
A rapid and sensitive reversed-phase high-performance liquid chromatography (HPLC) method using novel salting-out assisted liquid-liquid extraction technique has been developed for the quantitative determination of febuxostat (FEB), used for the...
10.
Patel N, Thakkar V, Metalia V, Baldaniya L, Gandhi T, Gohel M
Drug Dev Ind Pharm
. 2015 Dec;
42(9):1406-23.
PMID: 26716613
Context: The conventional liquid ophthalmic delivery systems exhibit short pre-corneal residence time and the relative impermeability to the cornea which leads to poor ocular bioavailability. Objective: The aim of this...